Biopsy Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Biopsy Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Biopsy Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A biopsy device is an instrument that aids in the removal of tissue samples from the body.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Biopsy Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Biopsy Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Biopsy Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Biopsy Devices Overview
4 Products under Development
4.1 Biopsy Devices - Pipeline Products by Stage of Development
4.2 Biopsy Devices - Pipeline Products by Segment
4.3 Biopsy Devices - Pipeline Products by Territory
4.4 Biopsy Devices - Pipeline Products by Regulatory Path
4.5 Biopsy Devices - Pipeline Products by Estimated Approval Date
4.6 Biopsy Devices - Ongoing Clinical Trials
5 Biopsy Devices - Pipeline Products under Development by Companies
5.1 Biopsy Devices Companies - Pipeline Products by Stage of Development
5.2 Biopsy Devices – Companies Pipeline Products by Stage of Development
6.95.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview
6.96 Zamar Care Company Overview
6.96.1 Zamar Care Pipeline Products & Ongoing Clinical Trials Overview
7 Biopsy Devices- Recent Developments
7.1 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
7.2 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
7.3 Oct 09, 2023: Stryker to Host Investor Day
7.4 Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
7.5 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
7.6 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
7.7 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer
7.8 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources
7.9 Aug 29, 2023: Coloplast Launches Offering to Raise Around Dkk 9 Billion Through Issue of New B Shares in a Directed Issue and Private Placement
7.1 Aug 29, 2023: Alpenglow Biosciences Presents the 3D Spatial Summit, an inaugural event for the field of 3D Spatial Biology to take place on September 21, 2023 in Cambridge, Massachusetts
7.11 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.12 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
7.13 Aug 15, 2023: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance
7.14 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
7.15 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.16 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
7.17 Jul 19, 2023: Boston Scientific Lays off 52 Amid California Facility Closure
7.18 Jun 09, 2023: FDA Roundup: June 9, 2023
7.19 May 15, 2023: iCAD reports financial results for first quarter ended March 31, 2023
7.2 May 11, 2023: NeoDynamics announces first quarter 2023
7.21 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.22 May 04, 2023: Cardinal Health reports third quarter fiscal year 2023 results and raises fiscal year 2023 non-gaap eps guidance
7.23 May 02, 2023: NeoDynamics Publishes Annual Report 2022
7.24 Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023
7.25 Apr 24, 2023: Notice of annual general meeting in NeoDynamics AB
7.26 Apr 17, 2023: iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives
7.27 Apr 12, 2023: Medtronic has a layoff in California
7.28 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
7.29 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders
7.3 Mar 27, 2023: iCad lays off 28% of its workforce in restructuring plan
7.31 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.32 Mar 13, 2023: iCAD Announces Leadership Transition
7.33 Mar 13, 2023: iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023
7.34 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
7.35 Mar 02, 2023: Children’s Hospital Los Angeles develops liquid biopsy test for pediatric solid tumors
7.36 Feb 17, 2023: NeoDynamics Announces full-year report 2022
7.37 Feb 15, 2023: NeoDynamics announces changes to the Board of Directors